找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Chemoradiation in Cancer Therapy; Hak Choy Book 2003 Springer Science+Business Media New York 2003 breast cancer.cancer.carcinoma.chemothe

[復(fù)制鏈接]
樓主: Conjecture
11#
發(fā)表于 2025-3-23 10:54:02 | 只看該作者
The Role of Chemoradiation in the Management of Esophageal Cancermor registry data obtained from the Surveillance, Epidemiology, and End Results (SEER) program has shown a decrease in the age-adjusted incidence of squamous cell carcinoma, while there has been a steady increase in the incidence of adenocarcinoma. Since the mid-1970s the incidence of adenocarcinoma
12#
發(fā)表于 2025-3-23 16:21:29 | 只看該作者
Chemoradiation in Therapy for Colon and Rectum Carcinomarall survival have been demonstrated with the use of combined-modality therapy in several randomized clinical trials performed over the past 25 yr. This chapter reviews the role of adjuvant chemotherapy and radiation therapy for colon and rectal cancer. Issues surrounding chemoradiation for rectal c
13#
發(fā)表于 2025-3-23 18:37:09 | 只看該作者
Chemoradiotherapy in Muscle-Invasive Bladder Cancernually. A majority of patients will present with nonmuscle-invasive disease, be treated adequately with transurethral resection (TURBT) with or without intravesical chemotherapy or immunotherapy, and will have only a 10–15% risk (higher for higher grades) of developing muscle-invasive disease. In co
14#
發(fā)表于 2025-3-24 00:18:08 | 只看該作者
15#
發(fā)表于 2025-3-24 05:34:06 | 只看該作者
Fluoropyrimidines as Radiation Sensitizersction in local failure rates, eradication of micrometastases to enhance distant control, preservation of organ function, and decrease in tumor bulk prior to surgery to make complete resection possible and improve survival.
16#
發(fā)表于 2025-3-24 07:52:17 | 只看該作者
Combined Modality Treatment of Small-Cell Lung Cancer port. LD accounts for approx 40% of all SCLC cases. Extensive-stage disease (ED) is tumor spread beyond these boundaries .. The presence of pleural effusions and/or supraclavicular lymphadenopathy have been considered LD by some investigators and ED by others.
17#
發(fā)表于 2025-3-24 14:07:19 | 只看該作者
18#
發(fā)表于 2025-3-24 17:58:10 | 只看該作者
19#
發(fā)表于 2025-3-24 19:00:04 | 只看該作者
20#
發(fā)表于 2025-3-24 23:13:59 | 只看該作者
2196-9906 multimodality approach to the management of solid tumors and speculate on possible future strategies for chemoradiation therapy. The authors detail applications of combined modality therapy in lung, esophageal, breast, gastric, pancreatic, colon, and rectal cancers. They also show how radiation int
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-14 18:13
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
荥经县| 海口市| 沂水县| 资阳市| 民县| 尤溪县| 博白县| 赤峰市| 额尔古纳市| 山阴县| 民丰县| 北海市| 丹凤县| 成安县| 济南市| 蚌埠市| 仙居县| 盘山县| 兰西县| 新乡市| 沾益县| 浏阳市| 南皮县| 循化| 姜堰市| 民权县| 汉沽区| 江达县| 株洲市| 深水埗区| 吉林市| 南丰县| 阿荣旗| 新乡市| 凤凰县| 左权县| 普陀区| 东山县| 中方县| 珠海市| 治县。|